J84.178 Código facturable y específico Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere

ICD-10-CM J84.178 identifies “Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Capítulo 10: Diseases of the respiratory system

Instrucciones del código

Inclusion terms4
  • Interstitial pneumonia (nonspecific) (usual) due to collagen vascular disease
  • Interstitial pneumonia (nonspecific) (usual) in diseases classified elsewhere
  • Organizing pneumonia due to collagen vascular disease
  • Organizing pneumonia in diseases classified elsewhere
Code first4
  • underlying disease, such as:
  • progressive systemic sclerosis (M34.0)
  • rheumatoid arthritis (M05.00-M06.9)
  • systemic lupus erythematosis (M32.0-M32.9)

Instrucciones de niveles superiores

Capítulos 10 · Diseases of the respiratory system (J00-J99)

Excludes 29
  • certain conditions originating in the perinatal period (P04-P96)
  • certain infectious and parasitic diseases (A00-B99)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • smoke inhalation (T59.81-)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Use additional code7
  • code, where applicable, to identify:
  • exposure to environmental tobacco smoke (Z77.22)
  • exposure to tobacco smoke in the perinatal period (P96.81)
  • history of tobacco dependence (Z87.891)
  • occupational exposure to environmental tobacco smoke (Z57.31)
  • tobacco dependence (F17.-)
  • tobacco use (Z72.0)
Note1

When a respiratory condition is described as occurring in more than one site and is not specifically indexed, it should be classified to the lower anatomic site (e.g. tracheobronchitis to bronchitis in J40).

J84 · Other interstitial pulmonary diseases

Excludes 12
  • drug-induced interstitial lung disorders (J70.2-J70.4)
  • interstitial emphysema (J98.2)
Excludes 21

lung diseases due to external agents (J60-J70)

Code also1

, if applicable, associated condition

J84.1 · Other interstitial pulmonary diseases with fibrosis

Excludes 11

pulmonary fibrosis (chronic) following radiation (J70.1)

Code also1

, if applicable, pulmonary fibrosis (chronic) due to inhalation of chemicals, gases, fumes or vapors (J68.4)

Referencias del índice oficial

Referencias del índice oficial (12)

Pneumonia(acute) (double) (migratory) (purulent) (septic) (unresolved) (12)

Historial oficial de conversión

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Fechas de vigencia 2020-10-01

Asignación anterior: J84.17

Referencias desde otros códigos (1)
Historial

Historial del código

Último cambio registrado · FY2026

ModificadoSin cambios
FY2026

Vigente desde

  • Cambios en instrucciones heredadas

Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere

Código de diagnóstico facturable

CDC/NCHS · FY2026

Todas las ediciones (13)

Todas las edicionesVigente desdeHistorial del código
FY20212020-10-01Añadido
FY2021 · 01-012021-01-01Sin cambios tabulares
FY20222021-10-01Sin cambios tabulares
FY2022 · 04-012022-04-01Sin cambios tabulares
FY20232022-10-01Sin cambios tabulares
FY2023 · 04-012023-04-01Sin cambios tabulares
FY20242023-10-01Sin cambios tabulares
FY2024 · 04-012024-04-01Sin cambios tabulares
FY20252024-10-01Cambios en instrucciones heredadas
FY2025 · 04-012025-04-01Sin cambios tabulares
FY20262025-10-01Cambios en instrucciones heredadas
FY2026 · April2026-04-01Sin cambios tabulares
FY20272026-10-01Sin cambios tabulares

Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.